{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:20:43Z","timestamp":1790626843055,"version":"4.1.0"},"reference-count":10,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,27]]},"DOI":"10.1182\/blood-2017-03-769075","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T12:30:29Z","timestamp":1493296229000},"page":"2342-2343","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["A major turning point in NK\/T-cell lymphoma?"],"prefix":"10.1182","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7091-8253","authenticated-orcid":false,"given":"Arnaud","family":"Jaccard","sequence":"first","affiliation":[{"name":"CENTRE HOSPITALIER UNIVERSITAIRE LIMOGES;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[{"name":"ASSISTANCE PUBLIQUE \u2013 H\u00d4PITAUX DE PARIS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111902441964900_B1","author":"Kwong"},{"issue":"13","key":"2019111902441964900_B2","first-page":"773","article-title":"Clinical characteristics and treatment of midline nasal and nasal type NK\/T cell lymphoma [in Chinese]","volume":"81","author":"Yong","year":"2001","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"issue":"6","key":"2019111902441964900_B3","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","article-title":"Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2 study","volume":"117","author":"Jaccard","year":"2011","journal-title":"Blood"},{"issue":"33","key":"2019111902441964900_B4","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"36","key":"2019111902441964900_B5","doi-asserted-by":"crossref","first-page":"58396","DOI":"10.18632\/oncotarget.11135","article-title":"The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)\/T-cell lymphoma, nasal type","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"2019111902441964900_B6","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","article-title":"A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies","volume":"109","author":"Perrine","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2019111902441964900_B7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/annonc\/mdv596","article-title":"Epstein-Barr virus reactivation in extranodal natural killer\/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin","volume":"27","author":"Kim","year":"2016","journal-title":"Ann Oncol"},{"issue":"8","key":"2019111902441964900_B8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","article-title":"Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins","volume":"32","author":"Bollard","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111902441964900_B9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF- B pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma.","volume":"9","author":"Bi","year":"2016","journal-title":"J Hematol Oncol"},{"issue":"15","key":"2019111902441964900_B10","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJMc1605684","article-title":"Targeting CD38 in refractory extranodal natural killer cell-T-cell lymphoma","volume":"375","author":"Hari","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/17\/2342\/1400037\/blood769075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/17\/2342\/1400037\/blood769075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:45:25Z","timestamp":1574131525000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/17\/2342\/35963\/A-major-turning-point-in-NKTcell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":10,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017,4,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-03-769075","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}